» Articles » PMID: 28982200

A Baculovirus-conjugated Mimotope Vaccine Targeting Mycobacterium Tuberculosis Lipoarabinomannan

Overview
Journal PLoS One
Date 2017 Oct 6
PMID 28982200
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Mycobacterium tuberculosis, the causative agent of tuberculosis, is a major cause of morbidity and mortality worldwide. However, an effective vaccine for M. tuberculosis is lacking. We panned a phage display library using monoclonal antibodies against M. tuberculosis liporabinomannan (LAM), an important component of the M. tuberculosis cell wall, and identified two peptide sequences, HSFKWLDSPRLR or SGVYKVAYDWQH, with high antibody affinity after multiple rounds of panning. Only the HSFKWLDSPRLR peptide induced an anti-LAM response when conjugated to either keyhole limpet hemocyanin (KLH) or to the baculovirus Autographa californica multicapsid nucleopolyherovirus (AcMNPV) when introduced into mice by injection or via intranasal inoculation, respectively. Vaccination with AcMNPV conjugated HSFKWLDSPRLR peptide delayed mortality in a mouse model of tuberculosis. Thus, we report a proof of principle M. tuberculosis vaccination strategy combining an anti-LAM mimotope with a baculovirus delivery system.

Citing Articles

B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis.

Rijnink W, Ottenhoff T, Joosten S Front Immunol. 2021; 12:640168.

PMID: 33679802 PMC: 7930078. DOI: 10.3389/fimmu.2021.640168.


Molluscan Compounds Provide Drug Leads for the Treatment and Prevention of Respiratory Disease.

Summer K, Browne J, Liu L, Benkendorff K Mar Drugs. 2020; 18(11).

PMID: 33228163 PMC: 7699502. DOI: 10.3390/md18110570.


Towards new TB vaccines.

Brazier B, McShane H Semin Immunopathol. 2020; 42(3):315-331.

PMID: 32189035 PMC: 7223498. DOI: 10.1007/s00281-020-00794-0.


Broad-spectrum capture of clinical pathogens using engineered Fc-mannose-binding lectin enhanced by antibiotic treatment.

Seiler B, Cartwright M, Dinis A, Duffy S, Lombardo P, Cartwright D F1000Res. 2019; 8:108.

PMID: 31275563 PMC: 6544136. DOI: 10.12688/f1000research.17447.1.


Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis.

Achkar J, Prados-Rosales R Curr Opin Immunol. 2018; 53:30-37.

PMID: 29656063 PMC: 6141321. DOI: 10.1016/j.coi.2018.04.004.

References
1.
Hsu C, Ho Y, Wang K, Hu Y . Investigation of optimal transduction conditions for baculovirus-mediated gene delivery into mammalian cells. Biotechnol Bioeng. 2004; 88(1):42-51. DOI: 10.1002/bit.20213. View

2.
Nair V, Franco L, Zacharia V, Khan H, Stamm C, You W . Microfold Cells Actively Translocate Mycobacterium tuberculosis to Initiate Infection. Cell Rep. 2016; 16(5):1253-1258. PMC: 4972672. DOI: 10.1016/j.celrep.2016.06.080. View

3.
Schlesinger L, Hull S, Kaufman T . Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol. 1994; 152(8):4070-9. View

4.
Hartman Z, Appledorn D, Amalfitano A . Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res. 2007; 132(1-2):1-14. PMC: 4039020. DOI: 10.1016/j.virusres.2007.10.005. View

5.
Chen T, Blanc C, Eder A, Prados-Rosales R, Souza A, Kim R . Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction. J Infect Dis. 2016; 214(2):300-10. PMC: 4918826. DOI: 10.1093/infdis/jiw141. View